PPT-Working with Investigational Assay Results
Author : phoebe | Published Date : 2023-10-04
Week 6 Correlative Trials A Case Based Approach J Kaitlin Morrison PhD Kathryn Pietrosimone PhD Victoria BaeJump MD and Lisa Carey MD What is a Device httpswwwfdagovmedicaldevicesclassifyyourmedicaldevicehowdetermineifyourproductmedicaldevice
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Working with Investigational Assay Resul..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Working with Investigational Assay Results: Transcript
Week 6 Correlative Trials A Case Based Approach J Kaitlin Morrison PhD Kathryn Pietrosimone PhD Victoria BaeJump MD and Lisa Carey MD What is a Device httpswwwfdagovmedicaldevicesclassifyyourmedicaldevicehowdetermineifyourproductmedicaldevice. Lucile White. Southern Research Institute. High Throughput Screening Center. What is HTS?. It is . a. . system. that uses specialized automation equipment and high density microtiter plates to screen a large number of “wells” in a short period of time.. Investigational Drug Control and . Patient Safety. CUMC RP. Robert B. MacArthur, Pharm.D.. “ Why does it take so long and cost so much for me to get my study pills ? “. Topics. What, Why, and How about CUMCRP. Investigational Drug Service. Department of Pharmacy. Role of an IDS Pharmacy in Drug . S. tudies. Why . Investigational Product Processes Need To Be Strictly Governed. Describe Good Clinical Practice (GCP) guidelines as they pertain to study drugs. Ashley Martin, Mark Ruddock, . Elizabeth Anderson. , Habib Alloush, Vyv Salisbury, Priyanka Mehta, Ann Smith, Graham Smith, John Lamont. AML is a condition affecting the adult population with a median age at presentation of 67 years. AML accounts for approximately 80% of acute leukaemia diagnosed in adults . Outpatient Clinical Trials. Jessica Rinaldi, CCRP. Jessica.Rinaldi@jefferson.edu. Farber Institute for Neurosciences. Learning Objectives. At the end of this activity, learners should be able to:. Understand FDA Regulations and ICH GCP Guidelines for disposition of Investigational Product in Clinical Trials. Outpatient Clinical Trials. Jessica Rinaldi, CCRP. Farber Institute for Neurosciences. 21 CFR §312.62. “. Disposition of drug. . . An . investigator is required to maintain adequate records of the disposition of the drug, including . Dr Rachel McCarthy. Spiral Software. SimSci-Esscor. User Group Conference. Houston, 15. th. October 2012. Introduction to Spiral. Founded . in 1998, . headquartered in . Cambridge, UK . Spiral provides tools and services that enable our clients to make the best choices in trading and refining crude oil. 1 King & Spalding May 22, 2014 Presentation for Clinical and Translational Science Center ─ University of California, Davis Health System Assay Optimization pre- Assay optimization and pre-validation are experiments that determine how a range of matrix and sample elements as well as assay conditions effect assay parameters and assay p Office of Research Protections, Policy, & Education. VHA Office of Research and Development. Department of Veterans Affairs . March 18, 2020. Dial in: 1 (213)-929-4232. Access Code: 152-743-880. Disclaimer. The content in this presentation was presented at HRS, May 2012. This presentation is for educational purposes only and should not be copied or presented without the permission of Boston Scientific Corp.. which is directly traceable to ERM-DA471/IFCC, the international standard reference material. The test utilizes Avian IGY antibodies to virtually eliminate some of the most common causes for interfe \n\r\n \r\r\n \n\r ! "#$%&\n '\r\n DESCRIPTIO Anaemia LIAISON Folate Tel. +39.0161.487526www.diasorin.comLIAISON Folate Limit of Blank (LoB): 0.28 ng/mL Limit of Detection (LoD): 0.61 ng/mL Limit of Quantication (LoQ): 1.00 ng/mL Part of
Download Document
Here is the link to download the presentation.
"Working with Investigational Assay Results"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents